Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E
about
Characterization of mouse and human GTP cyclohydrolase I genes. Mutations in patients with GTP cyclohydrolase I deficiencyCrystal structure of human pepsin and its complex with pepstatinPepsin-inhibitory activity of the uterine serpinsRegulation of human and mouse procathepsin E gene expressionCloning, expression and characterisation of murine procathepsin EInvolvement of cathepsin E in exogenous antigen processing in primary cultured murine microgliaEndosomal aspartic proteinases are required for invariant-chain processingGut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host.An aspartyl protease inhibitor orthologue expressed by Parelaphostrongylus tenuis is immunogenic in an atypical hostBCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.Selective detection of Cathepsin E proteolytic activity.Differential requirement for cathepsin D for processing of the full length and C-terminal fragment of the malaria antigen MSP1.Biochemical characterization and structural modeling of human cathepsin E variant 2 in comparison to the wild-type proteinImmunological genomics of Brugia malayi: filarial genes implicated in immune evasion and protective immunity.An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.Effects of interferon gamma and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases.Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniaeCathepsin E deficiency impairs autophagic proteolysis in macrophagesFine specificity of the genetically controlled immune response to native and recombinant gp15/400 (polyprotein allergen) of Brugia malayiCutaneous defenses against dermatophytes and yeasts.Cathepsin E expression by normal and premalignant cervical epithelium.The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligandsA limit to the divergent allele advantage model supported by variable pathogen recognition across HLA-DRB1 allele lineages.Cathepsin G: roles in antigen presentation and beyond.Cathepsin E Deficiency Ameliorates Graft-versus-Host Disease and Modifies Dendritic Cell Motility.Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice.Toward a Network Model of MHC Class II-Restricted Antigen Processing.Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease.Association of cathepsin E with tumor growth arrest through angiogenesis inhibition and enhanced immune responses.A new approach for distinguishing cathepsin E and D activity in antigen-processing organelles.Regulation of the human cathepsin E gene by the constitutive androstane receptorVectorial function of major histocompatibility complex class II in a human intestinal cell line.Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules.Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages.Aspartic proteinases in normal lung and interstitial pulmonary diseases.Coexpression of aspartic proteinases and human leukocyte antigen-DR in human transplanted lung.Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes.Natural history of Helicobacter pylori VacA toxin in human gastric epithelium in vivo: vacuoles and beyond.Cathepsin D is up-regulated in inflammatory bowel disease macrophages.
P2860
Q24315857-213D46F6-9B1D-4FF1-8AE2-F4E0BD9E9991Q24675181-EAD07335-3C3B-4CEB-82BB-147EE63CAECDQ24682518-73AC6CB0-6AFF-4FAA-9D5C-5E3F51DFF562Q28185600-EA148C5F-314E-4D56-90C7-A7B28085ADF9Q28586638-DC4843FB-2B90-4DF3-B53C-AB678820767CQ28589163-326B1E6A-344E-4A2C-AAEE-3C0FB3B23233Q28612976-F0655A78-E477-4087-A67C-7B31AECEE2EDQ30412140-265F5AF4-3009-453B-A185-CE8DE1F72871Q31091497-31E8FEDB-03E2-40CF-A841-121F901F4EC6Q33893983-1FFB04C0-7065-422E-9121-2A8C2A96CD6BQ34039858-67BD4F20-DB14-4FBD-96C5-EFB5442BE245Q34066910-CAA9404B-272A-4A03-B0C3-842F95E920E8Q34311356-63ADF858-F590-4AB5-AA4C-FF71C30EB8A6Q34319407-499B3E93-1869-41DB-818E-90E076E7D4A8Q34485526-ED79600E-FE44-4D6E-96DC-BC05D62C88B8Q34782453-BF9DF73D-1A28-4F2A-A237-185DE8BFAC4EQ34852939-EBE3A074-ED30-41FC-84AF-CF7D5A35B6F0Q35067790-084C71D3-71F6-4662-AD95-E1AAEC653D11Q35427213-426531A4-F484-4DB7-BF79-B460CA345FC8Q35535018-6A07E5E8-A5E4-40FE-A590-9F52D6806C7EQ35764288-08AA1B55-AC43-4B64-9D4A-C9E94F7933BAQ35821240-93D29194-2F1D-4C20-8AE7-4DEC47B489D0Q36370268-6B8731D6-AC50-4CD4-8045-FE11DD933F5CQ37320419-06EE887A-D3EA-45ED-8BE3-C11DF33A74FEQ37632012-CE95834D-E979-4D4D-A537-F9A69DA5050FQ37672390-D4D6D433-FC85-409E-8857-14FDD0B6160FQ37963808-5A423ACC-FEDE-479E-8AD5-C1065F3DB530Q38174882-51A70368-2FA9-4D8D-B756-C16D89C35584Q39411963-3F6230BF-71FF-4C8F-AC02-E47B83899F8FQ40058790-F4120348-BFF0-4F69-92F2-2ED6EE4D1F04Q40128905-1E801B83-C964-4072-AE74-994214DCE750Q40919665-5FE66FF3-37D9-4A84-A566-F57D696DB274Q40932107-8845FAEB-17AD-4B7B-8AAB-072F1D1664DAQ40945287-FA8EA253-22E5-4C52-AA89-669537EE2126Q41349830-5747F178-7FE2-45A4-A45B-AEC3813E3E88Q41550971-0E1E339B-B729-4CC6-8F5D-5DB47FC735C1Q42754045-9EA4F5AF-9878-43CC-A4E4-934EA2FD3A32Q43578153-09DDFF8F-FC6A-4F04-A50C-530ABCE60441Q47156398-B77139FD-0EA6-4C46-BE25-D0F151C439A0Q47927170-007EDE9A-812A-43EB-A3DA-C14AD7C4C94E
P2860
Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E
description
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1992
@ast
im Juni 1992 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1992/06/01)
@sk
vědecký článek publikovaný v roce 1992
@cs
wetenschappelijk artikel (gepubliceerd op 1992/06/01)
@nl
наукова стаття, опублікована в червні 1992
@uk
مقالة علمية (نشرت في يونيو 1992)
@ar
name
Antigen processing for present ...... quires cleavage by cathepsin E
@ast
Antigen processing for present ...... quires cleavage by cathepsin E
@en
Antigen processing for present ...... quires cleavage by cathepsin E
@nl
type
label
Antigen processing for present ...... quires cleavage by cathepsin E
@ast
Antigen processing for present ...... quires cleavage by cathepsin E
@en
Antigen processing for present ...... quires cleavage by cathepsin E
@nl
prefLabel
Antigen processing for present ...... quires cleavage by cathepsin E
@ast
Antigen processing for present ...... quires cleavage by cathepsin E
@en
Antigen processing for present ...... quires cleavage by cathepsin E
@nl
P2093
P356
P1476
Antigen processing for present ...... quires cleavage by cathepsin E
@en
P2093
B. M. Chain
I. M. Samloff
J. S. Ellis
K. Bennett
R. J. Peanasky
P304
P356
10.1002/EJI.1830220626
P407
P577
1992-06-01T00:00:00Z